Napolitano A - Search Results

1

Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study.

Lim SY, Ferro-López L, Barquin E, Lindsay D, Thway K, Smith MJ, Benson C, Jones RL, Napolitano A. Lim SY, et al. Among authors: napolitano a. Cancers (Basel). 2024 Feb 28;16(5):985. doi: 10.3390/cancers16050985. Cancers (Basel). 2024. PMID: 38473346 Free PMC article.

2

Ripretinib in advanced gastrointestinal stromal tumors: an overview of current evidence and drug approval.

Goggin C, Stansfeld A, Mahalingam P, Thway K, Smith MJ, Huang P, Jones RL, Napolitano A. Goggin C, et al. Among authors: napolitano a. Future Oncol. 2022 Aug;18(26):2967-2978. doi: 10.2217/fon-2022-0226. Epub 2022 Jul 26. Future Oncol. 2022. PMID: 35880452 Free article. Review.

3

KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment.

Napolitano A, Thway K, Smith MJ, Huang PH, Jones RL. Napolitano A, et al. Chemotherapy. 2022;67(2):81-90. doi: 10.1159/000521751. Epub 2022 Jan 4. Chemotherapy. 2022. PMID: 34983047 Free article. Review.

4

Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas.

Napolitano A, Ostler AE, Jones RL, Huang PH. Napolitano A, et al. Cells. 2021 Jun 17;10(6):1533. doi: 10.3390/cells10061533. Cells. 2021. PMID: 34204560 Free PMC article. Review.

5

Immune checkpoint inhibition in sarcomas: time to be histology-specific?

Napolitano A, Huang PH, Jones RL, Tu C. Napolitano A, et al. Lancet Oncol. 2022 Sep;23(9):1111-1112. doi: 10.1016/S1470-2045(22)00500-9. Lancet Oncol. 2022. PMID: 36055298 No abstract available.

6

Percutaneous cryoablation for desmoid fibromatosis: initial experience at a UK centre.

Johnston EW, Alves A, Messiou C, Napolitano A, Strauss D, Hayes A, Smith MJ, Benson C, Jones RL, Gennatas S, Fotiadis N. Johnston EW, et al. Among authors: napolitano a. Clin Radiol. 2022 Oct;77(10):784-793. doi: 10.1016/j.crad.2022.06.008. Epub 2022 Jul 16. Clin Radiol. 2022. PMID: 35850865

7

Current management of benign retroperitoneal tumors.

Tirotta F, Napolitano A, Noh S, Schmitz E, Nessim C, Patel D, Sicklick JK, Smith M, Thway K, van der Hage J, Ford SJ, Tseng WW. Tirotta F, et al. Among authors: napolitano a. Eur J Surg Oncol. 2023 Jun;49(6):1081-1090. doi: 10.1016/j.ejso.2022.07.006. Epub 2022 Jul 19. Eur J Surg Oncol. 2023. PMID: 35879135 Review.

8

Pharmacological strategies to reduce anthracycline-associated cardiotoxicity in cancer patients.

Stansfeld A, Radia U, Goggin C, Mahalingam P, Benson C, Napolitano A, Jones RL, Rosen SD, Karavasilis V. Stansfeld A, et al. Among authors: napolitano a. Expert Opin Pharmacother. 2022 Oct;23(14):1641-1650. doi: 10.1080/14656566.2022.2124107. Epub 2022 Sep 14. Expert Opin Pharmacother. 2022. PMID: 36102190 Review.

9

Real-world evidence for ultra rare cancers.

Mavroeidis L, Napolitano A, Huang P, Jones RL. Mavroeidis L, et al. Among authors: napolitano a. Rare Tumors. 2024 Feb 15;16:20363613241234207. doi: 10.1177/20363613241234207. eCollection 2024. Rare Tumors. 2024. PMID: 38371426 Free PMC article. No abstract available.

10

Management of Vascular Sarcoma.

Subramaniam A, Giani C, Napolitano A, Ravi V, Frezza AM, Jones RL. Subramaniam A, et al. Among authors: napolitano a. Surg Oncol Clin N Am. 2022 Jul;31(3):485-510. doi: 10.1016/j.soc.2022.03.014. Surg Oncol Clin N Am. 2022. PMID: 35715146 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

715 results

Search Page